Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea is one of the more commonly reported side effects of Mounjaro (tirzepatide). It tends to appear in the early weeks of treatment or after a dose increase, and for most people it settles within days as the body adjusts. It rarely signals a reason to stop treatment, but it does need managing carefully — and occasionally it signals something that requires prompt medical attention. As a prescription-only medicine, Mounjaro is only available following a clinical assessment; a prescriber reviews your full health picture before treatment begins and can support you if side effects arise. The NHS patient information page for tirzepatide lists gastrointestinal effects, including diarrhoea, among the most frequently reported reactions.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works by activating two gut-hormone receptors, GIP and GLP-1. One of the downstream effects is a slowing of gastric emptying: food moves more slowly from the stomach into the small intestine. That change in motility can temporarily disrupt the large intestine's normal rhythm too, producing loose or more frequent stools in some people. It is not a sign the medicine is doing something wrong. It is a direct pharmacological effect of how tirzepatide works.
The timing matters. Diarrhoea on Mounjaro is most likely in the first few weeks of treatment or in the days following a dose increase, when the body is recalibrating to a higher level of receptor activation. Our prescribers hear this question most weeks, patients are often relieved to know the pattern is predictable and usually self-limiting.
Eating smaller meals, avoiding high-fat or spicy foods around injection day, and spacing meals more evenly can all reduce the severity. Fibre intake is worth watching too: very high insoluble fibre can worsen loose stools, whereas soluble fibre tends to add bulk. Your prescriber or a dietitian is the right person to give personalised advice on adjusting your diet while on treatment. For a fuller overview of gastrointestinal reactions associated with tirzepatide, our Mounjaro side effects guide covers the full picture.
The priority is hydration. Diarrhoea causes fluid and electrolyte loss, and on a medicine that already reduces appetite, it is easy to underdrink. Sip water consistently throughout the day rather than trying to catch up in large amounts. Oral rehydration sachets are available from pharmacies without a prescription and can be useful if diarrhoea is frequent.
Rest, plain foods (rice, toast, boiled potato, cooked vegetables) and avoiding alcohol and caffeine are sensible general measures while symptoms last. If you are wondering whether diarrhoea is a side effect of Mounjaro, the short answer is yes, though most people find it is mild-to-moderate and resolves within a few days. It tends not to return at the same intensity once the body has adjusted to that dose level, the pattern often improves markedly before the next dose increase.
Over-the-counter loperamide can help reduce the frequency of loose stools in adults, but always check with a pharmacist before taking it alongside other medicines. Never adjust your Mounjaro dose or timing to try to avoid side effects, that is a clinical decision. Dose-related questions belong with your prescriber. You can read more specifically about managing diarrhoea from Mounjaro in our dedicated guide.
Most Mounjaro-related diarrhoea is uncomfortable but not dangerous. There are exceptions. Contact a healthcare professional promptly if:
Diarrhoea is severe or has lasted more than 48 hours without easing. Signs of dehydration appear: dark urine, dizziness on standing, a dry mouth, or reduced urination. You notice blood in your stool. You develop severe stomach pain, particularly pain that is persistent, radiates through to the back, or is accompanied by vomiting. That last combination is a red flag for acute pancreatitis, which is rare but serious. The MHRA flagged it formally in a Drug Safety Update in January 2026, and it applies across GLP-1 medicines including tirzepatide. Call 999 or go to A&E if the pain is severe and sudden.
For context on a related question patients often raise, our page on Mounjaro and pancreatic concerns addresses what the clinical evidence does and does not show. Kidney function can also be affected by prolonged dehydration from GI illness, so persistent diarrhoea always warrants a call to your GP or the prescribing service.
The UK has a robust mechanism for monitoring medicine safety in real-world use. If you experience diarrhoea or other side effects linked to tirzepatide, you can report it to the MHRA via the Yellow Card scheme. Reports from patients contribute to ongoing post-market surveillance. Mounjaro carries a Black Triangle (▼) designation, meaning it is under additional monitoring, your report counts.
At nume, at every repeat order, a GPhC-registered prescriber re-reviews your case. If diarrhoea has been persistent or severe, that is worth noting in your review. The prescriber may adjust the titration pace, suggest a longer stay at the current dose, or recommend further assessment. Treatment is never just dispensed and forgotten. If you have questions between consultations, our team is reachable seven days a week. You can find out more about how we work on our about us page, or read about the clinical oversight behind every prescription on our clinical team profile.
If you are weighing up Mounjaro against other licensed weight-loss treatments, our weight-loss treatment overview sets out the options clearly. And if you have decided you would like to speak to a prescriber, side effects and suitability are discussed as part of the free consultation, there is no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.